Haemonetics
HAE
101.71
-1.81
-1.75%
Haemonetics
US · HAE
#2165 by market cap
Listed 1970
101.71
-1.81
-1.75%
Live - 5344 symbols - heartbeat 201s ago
· 2026-10-08 07:40
Pre-market
122.99
+20.92%
After-hours
101.71
0.00%
- Market cap
- 4.63B
- P/E (TTM)i
- 49.14
- P/Bi
- 5.53
- EPSi
- 2.05
- Div yieldi
- 0.00%
- 52W posi
- 86%
Reader sentiment
Are you bullish or bearish on HAE?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 7 analysts
Buy
Avg price target
116.67 +14.7%
Price target rangecurrent 101.71
Low95.00
Avg116.67
High125.00
Buy 86%
Hold 14%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-01 | Barrington | -- | BUY | 118.00 |
| 2026-09-18 | Citi | -- | BUY | 123.00 |
| 2026-09-17 | Citi | -- | BUY | 123.00 |
| 2026-09-03 | Raymond James | -- | BUY | 125.00 |
| 2026-08-21 | Baird | -- | BUY | 119.00 |
| 2026-08-19 | Barrington | -- | BUY | 118.00 |
| 2026-08-18 | BofA Securities | -- | BUY | 120.00 |
| 2026-08-18 | Needham | -- | HOLD | -- |
| 2026-08-17 | BofA Securities | -- | BUY | 120.00 |
| 2026-08-13 | Citi | -- | HOLD | 92.00 |
| 2026-08-12 | BofA Securities | -- | BUY | 100.00 |
| 2026-08-11 | Mizuho Securities | -- | BUY | 95.00 |
| 2026-08-07 | Barrington | -- | BUY | 95.00 |
| 2026-08-07 | Raymond James | -- | BUY | 105.00 |
| 2026-08-07 | Baird | -- | BUY | 96.00 |
| 2026-08-07 | Citi | -- | HOLD | 92.00 |
| 2026-08-06 | Needham | -- | HOLD | -- |
| 2026-07-28 | BofA Securities | -- | BUY | 93.00 |
| 2026-07-15 | Mizuho Securities | -- | BUY | 90.00 |
| 2026-07-13 | Raymond James | -- | BUY | -- |
| 2026-07-08 | Citi | -- | HOLD | 79.00 |
| 2026-07-06 | Citi | -- | HOLD | 79.00 |
| 2026-06-26 | BTIG | -- | BUY | 84.00 |
| 2026-06-15 | Mizuho Securities | -- | BUY | 85.00 |
| 2026-06-15 | BTIG | -- | BUY | 84.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Buy
Analyst consensus
Buy
All 2 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
2 2
■ Upgrades■ Downgrades
- 2 upgrades vs 2 downgrades among tracked analyst rating changes.
- Most recent: Citi moved from Hold to Buy on 2026-09-17.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-09-17 | Citi | HOLD → BUY | 123.00 |
| 2026-05-22 | BofA Securities | HOLD → BUY | 80.00 |
| 2025-12-15 | Needham | BUY → HOLD | -- |
| 2025-12-11 | Citi | BUY → HOLD | 88.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2027/Q1 | 2026-08-06 | -- | ±10.14% | +1.70% (in line) |
| 2026/Q4 | 2026-05-07 | -- | ±10.65% | +3.23% (in line) |
| 2026/Q3 | 2026-02-05 | -- | ±11.31% | -1.41% (in line) |
| 2026/Q2 | 2025-11-06 | -- | ±12.33% | +32.31% (beat) |
| 2026/Q1 | 2025-08-07 | -- | ±9.46% | -26.58% (beat) |
| 2025/Q4 | 2025-05-08 | -- | ±10.84% | +5.85% (in line) |
| 2025/Q3 | 2025-02-06 | -- | ±11.44% | -11.58% (beat) |
| 2025/Q2 | 2024-11-07 | -- | ±11.30% | +10.71% (in line) |
| 2025/Q1 | 2024-08-08 | -- | ±6.42% | -10.84% (beat) |
| 2024/Q4 | 2024-05-09 | -- | ±8.34% | -0.70% (in line) |
| 2024/Q3 | 2024-02-08 | -- | ±9.07% | +1.30% (in line) |
| 2024/Q2 | 2023-11-02 | -- | ±10.30% | -1.08% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:40:22 · For reference only, not investment advice and not tailored to your situation.